LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy
Status:
Recruiting
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
Prospective cohort of patients treated with trifluridine/tipiracil, maximal sample size 250
patients. It is expected, that 89 patients will experience a grade 3-4 neutropenia and will
be included in the phase II.
Phase:
Phase 2
Details
Lead Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group